Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2045-2322
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production ; volume:7 ; number:1 ; day:22 ; month:11 ; year:2017 ; pages:1-12 ; date:12.2017
Scientific reports ; 7, Heft 1 (22.11.2017), 1-12, 12.2017

Schlagwort
Krebs
Onkologie

Urheber
Mogavero, Angela
Beteiligte Personen und Organisationen
Maiorana, Maria Valeria
Zanutto, Susanna
Varinelli, Luca
Bozzi, Fabio
Belfiore, Antonino
Volpi, Chiara C.
Gloghini, Annunziata
Pierotti, Marco A.
Gariboldi, Manuela
SpringerLink (Online service)

DOI
10.1038/s41598-017-16149-z
URN
urn:nbn:de:1111-20180409840
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:55 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Mogavero, Angela
  • Maiorana, Maria Valeria
  • Zanutto, Susanna
  • Varinelli, Luca
  • Bozzi, Fabio
  • Belfiore, Antonino
  • Volpi, Chiara C.
  • Gloghini, Annunziata
  • Pierotti, Marco A.
  • Gariboldi, Manuela
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling

Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling

Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway

Rosiglitazone metformin adduct inhibits hepatocellular carcinoma proliferation via activation of AMPK/p21 pathway

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects

Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway

Metformin alleviates neurocognitive impairment in aging via activation of AMPK/BDNF/PI3K pathway

ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway

ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway

Either, Rupert

Personenakten

Either, Rupert

Either, Rupert

Personenakten

Either, Rupert

Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons

Anxiolytic effect of antidiabetic metformin is mediated by AMPK activation in mPFC inhibitory neurons

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway

Metformin attenuates lung ischemia-reperfusion injury and necroptosis through AMPK pathway in type 2 diabetic recipient rats

Metformin attenuates lung ischemia-reperfusion injury and necroptosis through AMPK pathway in type 2 diabetic recipient rats

Verbundene Objekte